Viatris Inc. (0A5V)
LSE
Closed
Aug 24, 2026
Day's Range
15.8752 wk Range
9.43Overview - 0A5V - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
29.33B
P/E (Trailing)
‪10.72‬
Price / Sales (TTM)
‪1.26‬
Price / Book
‪0.93‬
EV / EBITDA
‪5.72‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪11.88%‬
Operating Margin
‪14.84%‬
Return on Assets
‪2.90%‬
Return on Equity
‪9.12%‬
Ownership
Shares Outstanding
1.15B
Float
1.19B
Held by Insiders
‪0.32%‬
Held by Institutions
‪78.19%‬
Price stats
Beta
‪1.15‬
50-Day Avg
‪16.61‬
200-Day Avg
‪14.55‬
Dividends
Payout Ratio
‪31.37%‬
Frequency
Quarterly
Market Cap - 0A5V - Viatris Inc.
Peers - 0A5V - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0A5VLSEViatris Inc.19.68BMarket Cap+27.45%52-week change10.73P/E (Trailing)‪11.88%‬Profit Margin
- HLNLSEHaleon plc3.19TMarket Cap+1.46%52-week change20.17P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc342.98BMarket Cap+2.31%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB167.10BMarket Cap+37.04%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited159.90BMarket Cap-23.64%52-week change184.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA63.83BMarket Cap+20.29%52-week change19.49P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0A5V - Viatris Inc.
About
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongside globally recognized established brands such as Lipitor, Norvasc,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
